Results 151 to 160 of about 64,314 (239)

Sustained disease remission with reduced‐intensity allogeneic hematopoietic cell transplant for VEXAS syndrome

open access: yes
HemaSphere, Volume 10, Issue 11, November 2026.
Bhavisha A. Patel   +34 more
wiley   +1 more source

A Case of Etanercept Induced Palmoplantar Pustular Psoriasis

open access: yes, 2012
Observations: Etanercept is a human recombinant soluble tumor necrosis factor (TNF-α) receptor fusion protein. Etanercept has been used successfully to treat a wide range of inflammatory disorders including psoriasis and psoriatic arthritis resistant to
Zennure Takçı   +3 more
core  

Comparison of efficacy of the tumour necrosis factor alpha blocking agents Etanercept and Infliximab in patients with active rheumatoid arthritis

open access: yes, 2005
Background: Tumor necrosis factor (TNF) antagonists are biologic response modifiers that have significantly improved the outcomes in patients with rheumatoid arthritis (RA).
SANGARI D   +8 more
core  

Etanercept in Steroid-Refractory Acute Graft Versus Host Disease: Clinical Response, Toxicity, and Long-Term Outcomes. [PDF]

open access: yesBlood Cell Ther
Chichra A   +13 more
europepmc   +1 more source

Impact of Regional Healthcare Policy Interventions on Biosimilar Use: A 10-year Evaluation of TNFα Inhibitors Utilization in Italy. [PDF]

open access: yesPharmaceut Med
Vitturi G   +40 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy